Systematic review for development of a medicinal products and medical devices prioritization framework
Resumen: BACKGROUND: The purpose of the research question is to develop an explicit priority setting methodology to support decision-making regarding Medicinal Products and Medical Devices to be included in hospital pharmacy practice. The development of a comprehensive prioritization system is the outcome essential for an important benefit to the healthcare system. The aim of this paper is to identify and analyze the processes and decision criteria used internationally for priority setting in order to establish a comprehensive set of strategic criteria for starting point for the development of a Medicinal Products and Medical Devices prioritization framework.
METHODS: A systematic search of the literature was carried out in December 2017, in the main biomedical electronic databases: Medline/PubMed, Embase, Centre for Reviews and Dissemination (CRD), and Cochrane. Eligibility criteria for inclusion were based on set of predefined criteria.
Systematic reviews and/or qualitative studies (interviews, surveys, expert consensus, etc) that aimed to identify prioritization criteria or develop general operational frameworks for the selection of health priorities were included. Data of the studies were analyzed and synthesized qualitatively.
RESULTS: A total of 17 documents complied with eligibility criteria, 15 were published in scientific journals and 2 were identified through web pages. The studies showed great heterogeneity. A total of 56 potentially relevant priority setting criteria were identified, which could be grouped in 8 categories: 1) Need for intervention; 2) Outcomes of intervention; 3) Type of benefit; 4) Economic consequences; 5) Existing knowledge/quality of evidence and uncertainties; 6) Implementation complexity/feasibility; 7) Priority, justice and equity; and 8) Context.
DISCUSSION: There are no standardized processes for priority setting, despite the fact some general consensus and common trends have been identified regarding criteria, models and strategies, and key actors. This research provides a thorough analysis of these approaches and offers recommendations for implementing successful prioritization approaches.

Idioma: Inglés
DOI: 10.1002/phar.2144
Año: 2018
Publicado en: PHARMACOTHERAPY 38, 7 (2018), e77
ISSN: 0277-0008

Factor impacto JCR: 3.045 (2018)
Categ. JCR: PHARMACOLOGY & PHARMACY rank: 97 / 266 = 0.365 (2018) - Q2 - T2
Factor impacto SCIMAGO: 1.156 - Pharmacology (medical) (Q1)

Tipo y forma: Comunicación congreso (Versión definitiva)
Área (Departamento): Área Medic.Prevent.Salud Públ. (Dpto. Microb.Med.Pr.,Sal.Públ.)

Derechos Reservados Derechos reservados por el editor de la revista


Exportado de SIDERAL (2020-01-13-14:54:37)


Visitas y descargas

Este artículo se encuentra en las siguientes colecciones:
Artículos



 Registro creado el 2018-08-16, última modificación el 2020-01-13


Versión publicada:
 PDF
Valore este documento:

Rate this document:
1
2
3
 
(Sin ninguna reseña)